RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCIE SCOPUS

    Minimal Residual Disease Detection in Acute Leukemia Patients by Flow Cytometric Assay of Cross-lineage Antigen Expression

    한글로보기

    https://www.riss.kr/link?id=A101631474

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Background : It has been demonstrated that flow cytometric detection of minimal residual disease (MRD) has a prognostic significance in the treatment of patients with acute leukemia. We investigated the significance of flow cytometric MRD detection for the first time in Korea.
    Methods : We analyzed the results of MRD detection in morphologically complete remission bone marrow aspirates from 89 patients with newly-diagnosed or relapsed acute leukemia, in which leukemic cells had cross-lineage antigen expression. Patients were grouped based on MRD frequencies:≥1.0%, high MRD; <1.0%, low MRD.
    Results : Forty-seven ALL patients consisted of 10 with high and 37 with low MRD levels. Patients with high MRD levels showed a tendency of more frequent relapse than those with low MRD levels (40.0% and 13.5%, respectively) (P=0.08). High MRD group showed a tendency of short relapsefree survival (RFS) and overall survival (OS), although the differences were not statistically significant. Forty-two AML patients consisted of 16 with high and 26 with low MRD levels. There were no correlations between the MRD levels and relapse rate, RFS or OS. AML patients with high MRD levels showed significantly higher rate of unfavorable cytogenetic risk categories and lower rate of favorable risk categories (P=0.03).
    Conclusions : MRD detection by flow cytometric assay of cross-lineage antigen expression would be useful in predicting treatment outcome in patients with ALL rather than AML. We expect that the establishment of the standardization of methods, time to test or antibody combination would be achieved through further trials in this country. (Korean J Lab Med 2010;30:533-9)
    번역하기

    Background : It has been demonstrated that flow cytometric detection of minimal residual disease (MRD) has a prognostic significance in the treatment of patients with acute leukemia. We investigated the significance of flow cytometric MRD detection fo...

    Background : It has been demonstrated that flow cytometric detection of minimal residual disease (MRD) has a prognostic significance in the treatment of patients with acute leukemia. We investigated the significance of flow cytometric MRD detection for the first time in Korea.
    Methods : We analyzed the results of MRD detection in morphologically complete remission bone marrow aspirates from 89 patients with newly-diagnosed or relapsed acute leukemia, in which leukemic cells had cross-lineage antigen expression. Patients were grouped based on MRD frequencies:≥1.0%, high MRD; <1.0%, low MRD.
    Results : Forty-seven ALL patients consisted of 10 with high and 37 with low MRD levels. Patients with high MRD levels showed a tendency of more frequent relapse than those with low MRD levels (40.0% and 13.5%, respectively) (P=0.08). High MRD group showed a tendency of short relapsefree survival (RFS) and overall survival (OS), although the differences were not statistically significant. Forty-two AML patients consisted of 16 with high and 26 with low MRD levels. There were no correlations between the MRD levels and relapse rate, RFS or OS. AML patients with high MRD levels showed significantly higher rate of unfavorable cytogenetic risk categories and lower rate of favorable risk categories (P=0.03).
    Conclusions : MRD detection by flow cytometric assay of cross-lineage antigen expression would be useful in predicting treatment outcome in patients with ALL rather than AML. We expect that the establishment of the standardization of methods, time to test or antibody combination would be achieved through further trials in this country. (Korean J Lab Med 2010;30:533-9)

    더보기

    참고문헌 (Reference)

    1 신소영, "급성백혈병 완전 관해 골수에서 항원형 이상 세포의 분포" 대한진단검사의학회 28 (28): 1-7, 2008

    2 Al-Mawali A, "The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia" 131 : 16-26, 2009

    3 Buccisano F, "The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia" 20 : 1783-1789, 2006

    4 Chung NG, "The detection and significance of minimal residual disease in acute and chronic leukemia" 68 : 371-385, 2006

    5 Campana D, "Status of minimal residual disease testing in childhood haematological malignancies" 143 : 481-489, 2008

    6 Ciudad J, "Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia" 16 : 3774-3781, 1998

    7 Dworzak MN, "Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia" 99 : 1952-1958, 2002

    8 Coustan-Smith E, "Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lym phoblastic leukemia" 100 : 52-58, 2002

    9 Kern W, "Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia" 89 : 528-540, 2004

    10 Kern W, "Monitoring of minimal residual disease in acute myeloid leukemia" 112 : 4-16, 2008

    1 신소영, "급성백혈병 완전 관해 골수에서 항원형 이상 세포의 분포" 대한진단검사의학회 28 (28): 1-7, 2008

    2 Al-Mawali A, "The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia" 131 : 16-26, 2009

    3 Buccisano F, "The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia" 20 : 1783-1789, 2006

    4 Chung NG, "The detection and significance of minimal residual disease in acute and chronic leukemia" 68 : 371-385, 2006

    5 Campana D, "Status of minimal residual disease testing in childhood haematological malignancies" 143 : 481-489, 2008

    6 Ciudad J, "Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia" 16 : 3774-3781, 1998

    7 Dworzak MN, "Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia" 99 : 1952-1958, 2002

    8 Coustan-Smith E, "Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lym phoblastic leukemia" 100 : 52-58, 2002

    9 Kern W, "Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia" 89 : 528-540, 2004

    10 Kern W, "Monitoring of minimal residual disease in acute myeloid leukemia" 112 : 4-16, 2008

    11 Vidriales MB, "Minimal residual disease monitoring by flow cytometry" 16 : 599-612, 2003

    12 Feller N, "MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia" 18 : 1380-1390, 2004

    13 Venditti A, "Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia" 96 : 3948-3952, 2000

    14 San Miguel JF, "Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients" 90 : 2465-2470, 1997

    15 Plata E, "Flowcytometric detection of minimal residual disease with atypical antigen combinations in patients with de novo acute myeloid leukemia" 79 : 543-546, 2000

    16 San Miguel JF, "Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification" 98 : 1746-1751, 2001

    17 Kern W, "Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia" 104 : 3078-3085, 2004

    18 Kern W, "Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow" 88 : 646-653, 2003

    19 Mrozek K, "Cytogenetics in acute leukemia" 18 : 115-136, 2004

    20 Coustan-Smith E, "Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia" 123 : 243-252, 2003

    21 Borowitz MJ, "Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study" 111 : 5477-5485, 2008

    22 Coustan-Smith E, "Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse" 18 : 499-504, 2004

    23 Venditti A, "Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia" 11 : 349-357, 2002

    24 Coustan-Smith E, "Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia" 96 : 2691-2696, 2000

    25 Coustan-Smith E, "A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome" 108 : 97-102, 2006

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2012-05-21 학술지명변경 한글명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
    외국어명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
    KCI등재
    2011-01-01 등재 학술지 분리 (기타) KCI등재
    2010-06-29 학술지명변경 한글명 : 대한진단검사의학회지 -> The Korean Journal of Laboratory Medicine KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2007-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2005-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2002-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    1999-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 1.51 0.18 1.15
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.91 0.81 0.458 0.08
    더보기
    해외이동버튼